Ned Block - Publications

Affiliations: 
New York University, New York, NY, United States 
Area:
philosophy of mind
Website:
https://www.nyu.edu/gsas/dept/philo/faculty/block/

12/318 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Block N. What Is Wrong with the No-Report Paradigm and How to Fix It. Trends in Cognitive Sciences. PMID 31676213 DOI: 10.1016/j.tics.2019.10.001  0.301
2017 Peters MAK, Kentridge RW, Phillips I, Block N. Does unconscious perception really exist? Continuing the ASSC20 debate. Neuroscience of Consciousness. 2017: nix015. PMID 30042847 DOI: 10.1093/Nc/Nix015  0.323
2012 O'Regan JK, Block N. Discussion of J. Kevin O'Regan's "Why Red Doesn't Sound Like a Bell: Understanding the Feel of Consciousness" Review of Philosophy and Psychology. 3: 89-108. DOI: 10.1007/s13164-012-0090-7  0.324
2011 Block N. Perceptual consciousness overflows cognitive access. Trends in Cognitive Sciences. 15: 567-75. PMID 22078929 DOI: 10.1016/j.tics.2011.11.001  0.346
2007 Block N. Consciousness, accessibility, and the mesh between psychology and neuroscience. The Behavioral and Brain Sciences. 30: 481-99; discussion 4. PMID 18366828 DOI: 10.1017/S0140525X07002786  0.336
2007 Block N. Overflow, access, and attention Behavioral and Brain Sciences. 30: 530-542. DOI: 10.1017/S0140525X07003111  0.31
2005 Block N. Two neural correlates of consciousness. Trends in Cognitive Sciences. 9: 46-52. PMID 15668096 DOI: 10.1016/j.tics.2004.12.006  0.316
2005 Block N. The merely verbal problem of consciousness Trends in Cognitive Sciences. 9: 270. DOI: 10.1016/J.Tics.2005.04.009  0.312
1999 Block N, Stalnaker R. Conceptual analysis, dualism, and the explanatory gap Philosophical Review. 108: 1-46. DOI: 10.2307/2998259  0.616
1996 Block N. How can we find the neural correlate of consciousness? Trends in Neurosciences. 19: 456-9. PMID 8931266 DOI: 10.1016/S0166-2236(96)20049-9  0.324
1996 Block N. Mental Paint and Mental Latex Philosophical Issues. 7: 19-49. DOI: 10.2307/1522889  0.323
1972 Block N, Fodor JA. What psychological states are not The Philosophical Review. 81: 159. DOI: 10.2307/2183991  0.533
Low-probability matches (unlikely to be authored by this person)
2010 Block N. Attention And Mental Paint Philosophical Issues. 20: 23-63. DOI: 10.1111/J.1533-6077.2010.00177.X  0.3
2014 Block N. Seeing-As in the Light of Vision Science Philosophy and Phenomenological Research. DOI: 10.1111/phpr.12135  0.295
1995 Block N. On a confusion about a function of consciousness Behavioral and Brain Sciences. 18: 227-247. DOI: 10.1017/S0140525X00038188  0.294
2018 Block N. If perception is probabilistic, why does it not seem probabilistic? Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 373. PMID 30061455 DOI: 10.1098/rstb.2017.0341  0.292
2016 Block N. Tweaking the concepts of perception and cognition. The Behavioral and Brain Sciences. 39: e232. PMID 28355865 DOI: 10.1017/S0140525X15002733  0.291
1992 Block N. Begging the question against phenomenal consciousness Behavioral and Brain Sciences. 15: 205-206. DOI: 10.1017/S0140525X00068266  0.287
2015 Block N. The Anna Karenina Principle and Skepticism about Unconscious Perception Philosophy and Phenomenological Research. DOI: 10.1111/phpr.12258  0.285
1983 Block N. The Photographic Fallacy in the Debate about Mental Imagery NoûS. 17: 651. DOI: 10.2307/2215087  0.283
2014 Block N. The Defective Armchair: A Reply to Tye Thought: a Journal of Philosophy. 3: 159-165. DOI: 10.1002/Tht3.124  0.279
1983 Block N. Resemblance and imaginal representation Behavioral and Brain Sciences. 6: 142-143. DOI: 10.1017/S0140525X00015120  0.269
1999 Block N. Sexism, Racism, Ageism, and the Nature of Consciousness Philosophical Topics. 26: 39-70. DOI: 10.5840/Philtopics1999261/233  0.265
1983 Block N. Mental Pictures and Cognitive Science The Philosophical Review. 92: 499. DOI: 10.2307/2184879  0.264
2013 Block N. Seeing and Windows of Integration Thought: a Journal of Philosophy. 2: 29-39. DOI: 10.1002/Tht3.62  0.263
2001 Block N. Paradox and cross purposes in recent work on consciousness. Cognition. 79: 197-219. PMID 11164028 DOI: 10.1016/S0010-0277(00)00129-3  0.258
2009 Block N. Consciousness and cognitive access Neuroscience Research. 65. DOI: 10.1016/J.Neures.2009.09.1651  0.257
2008 Block N. Anti‐Reductionism Slaps Back NoûS. 31: 107-132. DOI: 10.1111/0029-4624.31.S11.5  0.257
2017 Morales J, Mouradi Y, Sergent C, Block N, Taschereau-Dumouchel V, Rosenthal D, Grimaldi P, Lau H. Measuring away an attentional confound? Neuroscience of Consciousness. 2017: nix018. PMID 30042850 DOI: 10.1093/Nc/Nix018  0.256
2012 Block N. The Grain of Vision and the Grain of Attention Thought: a Journal of Philosophy. 1: 170-184. DOI: 10.1002/Tht3.28  0.254
2014 Block N, Carmel D, Fleming SM, Kentridge RW, Koch C, Lamme VA, Lau H, Rosenthal D. Consciousness science: real progress and lingering misconceptions. Trends in Cognitive Sciences. 18: 556-7. PMID 25287833 DOI: 10.1016/J.Tics.2014.09.004  0.252
2003 Block N. Do Causal Powers Drain Away Philosophy and Phenomenological Research. 67: 133-150. DOI: 10.1111/J.1933-1592.2003.Tb00029.X  0.245
2003 Block N. Neurophilosophy or Philoneuroscience Science. 301: 1328-1329. DOI: 10.1126/Science.1084934  0.245
2005 Block N. Action in Perception by Alva Noë The Journal of Philosophy. 102: 259-272. DOI: 10.5840/Jphil2005102524  0.243
1981 Block N. Psychologism and Behaviorism The Philosophical Review. 90: 5. DOI: 10.2307/2184371  0.241
1987 Block N. Advertisement for a Semantics for Psychology Midwest Studies in Philosophy. 10: 615-678. DOI: 10.1111/J.1475-4975.1987.Tb00558.X  0.24
1980 Block N. Are Absent Qualia Impossible The Philosophical Review. 89: 257. DOI: 10.2307/2184650  0.237
2019 Michel M, Beck D, Block N, Blumenfeld H, Brown R, Carmel D, Carrasco M, Chirimuuta M, Chun M, Cleeremans A, Dehaene S, Fleming SM, Frith C, Haggard P, He BJ, et al. Opportunities and challenges for a maturing science of consciousness. Nature Human Behaviour. 3: 104-107. PMID 30944453 DOI: 10.1038/S41562-019-0531-8  0.237
2013 Block N, Siegel S. Attention and perceptual adaptation. The Behavioral and Brain Sciences. 36: 205-6. PMID 23663745 DOI: 10.1017/S0140525X12002245  0.235
1992 Hayes P, Harnad S, Perlis DR, Block N. Virtual Symposium on Virtual Mind Minds and Machines. 2: 217-238. DOI: 10.1007/Bf02454221  0.232
2012 Block N. Response to Kouider et al.: Which view is better supported by the evidence? Trends in Cognitive Sciences. 16: 141-142. DOI: 10.1016/j.tics.2012.01.008  0.23
2014 Block N. Rich conscious perception outside focal attention. Trends in Cognitive Sciences. 18: 445-7. PMID 24890010 DOI: 10.1016/j.tics.2014.05.007  0.228
2000 Block N. How not to find the neural correlate of consciousness Intellectica. 31: 125-136. DOI: 10.3406/Intel.2000.1604  0.227
1997 Block N. Biology versus computation in the study of consciousness Behavioral and Brain Sciences. 20: 159-166. DOI: 10.1017/S0140525X97330052  0.227
1998 Block N, Tye M. Is Experiencing Just Representing?@@@Ten Problems of Consciousness Philosophy and Phenomenological Research. 58: 663. DOI: 10.2307/2653766  0.223
1995 Block N. How heritability misleads about race. Cognition. 56: 99-128. PMID 7554794 DOI: 10.1016/0010-0277(95)00678-R  0.222
2018 Carter O, Hohwy J, van Boxtel J, Lamme V, Block N, Koch C, Tsuchiya N. Conscious machines: Defining questions. Science (New York, N.Y.). 359: 400. PMID 29371459 DOI: 10.1126/Science.Aar4163  0.22
1990 Block N. Consciousness and accessibility Behavioral and Brain Sciences. 13: 596-598. DOI: 10.1017/S0140525X00080316  0.22
1994 Block N. What Is Dennett’s Theory a Theory of? Philosophical Topics. 22: 23-40. DOI: 10.5840/Philtopics1994221/22  0.215
2003 Block N. Tactile sensation via spatial perception. Trends in Cognitive Sciences. 7: 285-286. PMID 12860185 DOI: 10.1016/S1364-6613(03)00132-3  0.214
2002 Block N. The Harder Problem of Consciousness The Journal of Philosophy. 99: 391-425. DOI: 10.2307/3655621  0.211
1991 Block N. Evidence against epiphenomenalism Behavioral and Brain Sciences. 14: 670-672. DOI: 10.1017/S0140525X0007179X  0.207
1995 Block N. How many concepts of consciousness? Behavioral and Brain Sciences. 18: 272-287. DOI: 10.1017/S0140525X00038486  0.205
1993 Block N. Holism, Hyper‐analyticity and Hyper‐compositionality Mind & Language. 8: 1-26. DOI: 10.1111/J.1468-0017.1993.Tb00267.X  0.204
2020 Block N. Finessing the Bored Monkey Problem. Trends in Cognitive Sciences. PMID 31987718 DOI: 10.1016/j.tics.2019.12.012  0.203
2011 Block N. The higher order approach to consciousness is defunct Analysis. 71: 419-431. DOI: 10.1093/analys/anr037  0.2
2007 Block N. Wittgenstein and qualia Nous-Supplement: Philosophical Perspectives. 21: 73-115. DOI: 10.1111/J.1520-8583.2007.00121.X  0.199
1993 Block N. Consciousness Explained by Daniel C. Dennett The Journal of Philosophy. 90: 181-193. DOI: 10.5840/Jphil199390448  0.196
1998 Block N. How to Find the Neural Correlate of Consciousness Royal Institute of Philosophy Supplement. 43: 23-34. DOI: 10.1017/S1358246100004288  0.192
1987 Block N, Campell J. Functional Role and Truth Conditions Aristotelian Society Supplementary Volume. 61: 157-184. DOI: 10.1093/Aristoteliansupp/61.1.157  0.184
1999 Block N. Ridiculing social constructivism about phenomenal consciousness Behavioral and Brain Sciences. 22: 199-201. DOI: 10.1017/S0140525X99221802  0.183
2011 Block N. Response to rosenthal and weisberg Analysis. 71: 443-448. DOI: 10.1093/analys/anr036  0.179
2021 Raccah O, Block N, Fox KCR. Does the Prefrontal Cortex Play an Essential Role in Consciousness? Insights from Intracranial Electrical Stimulation of the Human Brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 41: 2076-2087. PMID 33692142 DOI: 10.1523/JNEUROSCI.1141-20.2020  0.178
1979 Block N. A confusion about innateness Behavioral and Brain Sciences. 2: 27-29. DOI: 10.1017/S0140525X00060453  0.177
1990 Pesetsky D, Block N. Complexity and adaptation Behavioral and Brain Sciences. 13: 750-752. DOI: 10.1017/S0140525X00081279  0.177
1993 Block N. Holism, Hyper-Analyticity and Hyper-Compositionality Philosophical Issues. 3: 37. DOI: 10.2307/1522937  0.175
1980 Block N. What intuitions about homunculi don't show Behavioral and Brain Sciences. 3: 425-426. DOI: 10.1017/S0140525X0000577X  0.169
1999 Block N. Jack and Jill have shifted spectra Behavioral and Brain Sciences. 22: 946-947. DOI: 10.1017/S0140525X99242215  0.166
2018 Block N. If perception is probabilistic, why does it not seem probabilistic? Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 373. PMID 30061455 DOI: 10.1098/rstb.2017.0341  0.163
2023 Walker EY, Pohl S, Denison RN, Barack DL, Lee J, Block N, Ma WJ, Meyniel F. Studying the neural representations of uncertainty. Nature Neuroscience. PMID 37814025 DOI: 10.1038/s41593-023-01444-y  0.159
2008 Block N. Phenomenal and access consciousness Ned Block and Cynthia MacDonald: Consciousness and cognitive access Proceedings of the Aristotelean Society. 108: 289-317. DOI: 10.1111/j.1467-9264.2008.00247.x  0.127
2012 Tsuchiya N, Block N, Koch C. Top-down attention and consciousness: comment on Cohen et al. Trends in Cognitive Sciences. 16: 527; author reply 52. PMID 23026022 DOI: 10.1016/j.tics.2012.09.004  0.12
2023 Block N. Perception is iconic, perceptual working memory is discursive. The Behavioral and Brain Sciences. 46: e265. PMID 37766617 DOI: 10.1017/S0140525X23001899  0.12
1997 Ressler N, Block N. A motivational perspective of conscious experience [2] (multiple letters) Trends in Neurosciences. 20: 450. PMID 9347611  0.107
2005 Baars BJ, Laureys S, Block N. One, not two, neural correlates of consciousness (multiple letters) Trends in Cognitive Sciences. 9: 269-270. PMID 15925803 DOI: 10.1016/j.tics.2005.04.008  0.094
2014 Mandelli ML, Caverzasi E, Binney RJ, Henry ML, Lobach I, Block N, Amirbekian B, Dronkers N, Miller BL, Henry RG, Gorno-Tempini ML. Frontal white matter tracts sustaining speech production in primary progressive aphasia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 9754-67. PMID 25031413 DOI: 10.1523/Jneurosci.3464-13.2014  0.091
2009 Deshpande AR, Block N, Barkin JS. Taking a closer look at the rectal examination: beyond the basics. The American Journal of Gastroenterology. 104: 246-7; author reply . PMID 19098881 DOI: 10.1038/ajg.2008.46  0.086
2007 Block N. Max Black's Objection to Mind-Body Identity Phenomenal Concepts and Phenomenal Knowledge: New Essays On Consciousness and Physicalism. DOI: 10.1093/acprof:oso/9780195171655.003.0012  0.083
2013 Wainer AL, Block N, Donnellan MB, Ingersoll B. The broader autism phenotype and friendships in non-clinical dyads. Journal of Autism and Developmental Disorders. 43: 2418-25. PMID 23430176 DOI: 10.1007/S10803-013-1789-8  0.08
2012 Jaszberenyi M, Rick FG, Szalontay L, Block NL, Zarandi M, Cai RZ, Schally AV. Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease. Aging. 4: 755-67. PMID 23211425  0.078
2015 Miller ZA, Hinkley LB, Herman A, Honma S, Findlay A, Block N, Ketelle R, Rabinovici G, Rosen H, Nagarajan SS, Miller BL, Gorno-Tempini ML. Anomalous functional language lateralization in semantic variant PPA. Neurology. 84: 204-6. PMID 25471393 DOI: 10.1212/Wnl.0000000000001131  0.077
2011 Block N. The Anna Karenina theory of the unconscious Neuropsychoanalysis. 13: 34-37.  0.077
2003 Block N. Tactile sensation via spatial perception [3] Trends in Cognitive Sciences. 7: 285-286. DOI: 10.1016/S1364-6613(03)00132-3  0.069
2003 Block N. Petrus Hispanus Lectures 2003: The harder problem of consciousness Disputatio. 5-49.  0.067
2014 Popovics P, Schally AV, Szalontay L, Block NL, Rick FG. Targeted cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AEZS-108 (AN-152), inhibits the growth of DU-145 human castration-resistant prostate cancer in vivo and in vitro through elevating p21 and ROS levels. Oncotarget. 5: 4567-78. PMID 24994120  0.06
2013 Rick FG, Block NL, Schally AV. Agonists of luteinizing hormone-releasing hormone in prostate cancer. Expert Opinion On Pharmacotherapy. 14: 2237-47. PMID 23984804 DOI: 10.1517/14656566.2013.834328  0.06
2016 Ranasinghe KG, Rankin KP, Pressman PS, Perry DC, Lobach IV, Seeley WW, Coppola G, Karydas AM, Grinberg LT, Shany-Ur T, Lee SE, Rabinovici GD, Rosen HJ, Gorno-Tempini ML, Boxer AL, ... ... Block N, et al. Distinct Subtypes of Behavioral Variant Frontotemporal Dementia Based on Patterns of Network Degeneration. Jama Neurology. PMID 27429218 DOI: 10.1001/Jamaneurol.2016.2016  0.06
2014 Lee SE, Khazenzon AM, Trujillo AJ, Guo CC, Yokoyama JS, Sha SJ, Takada LT, Karydas AM, Block NR, Coppola G, Pribadi M, Geschwind DH, Rademakers R, Fong JC, Weiner MW, et al. Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion. Brain : a Journal of Neurology. 137: 3047-60. PMID 25273996 DOI: 10.1093/Brain/Awu248  0.057
2015 Schally AV, Block NL, Rick FG. New therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormones. Asian Journal of Andrology. PMID 26112478 DOI: 10.4103/1008-682X.152819  0.057
2014 Ludwig B, Barthel A, Reichel A, Block NL, Ludwig S, Schally AV, Bornstein SR. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus. Vitamins and Hormones. 95: 195-222. PMID 24559919 DOI: 10.1016/B978-0-12-800174-5.00008-9  0.056
2014 Jaszberenyi M, Rick FG, Popovics P, Block NL, Zarandi M, Cai RZ, Vidaurre I, Szalontay L, Jayakumar AR, Schally AV. Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists. Proceedings of the National Academy of Sciences of the United States of America. 111: 781-6. PMID 24379381 DOI: 10.1073/pnas.1322622111  0.055
2014 Szalontay L, Schally AV, Popovics P, Vidaurre I, Krishan A, Zarandi M, Cai RZ, Klukovits A, Block NL, Rick FG. Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function. Cell Cycle (Georgetown, Tex.). 13: 2790-7. PMID 25486366 DOI: 10.4161/15384101.2015.945879  0.054
2014 Fahrenholtz CD, Rick FG, Garcia MI, Zarandi M, Cai RZ, Block NL, Schally AV, Burnstein KL. Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 111: 1084-9. PMID 24395797 DOI: 10.1073/Pnas.1323102111  0.054
2011 Rick FG, Schally AV, Block NL, Nadji M, Szepeshazi K, Zarandi M, Vidaurre I, Perez R, Halmos G, Szalontay L. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia. Proceedings of the National Academy of Sciences of the United States of America. 108: 3755-60. PMID 21321192 DOI: 10.1073/Pnas.1018086108  0.053
2015 Block NL, Goodman SM, Hackett SJ, Bates JM, Raherilalao MJ. Potential merger of ancient lineages in a passerine bird discovered based on evidence from host-specific ectoparasites. Ecology and Evolution. 5: 3743-55. PMID 26380702 DOI: 10.1002/Ece3.1639  0.05
1985 Reese DH, Gratzner HG, Block NL, Politano VA. Control of growth, morphology, and alkaline phosphatase activity by butyrate and related short-chain fatty acids in the retinoid-responsive 9-1C rat prostatic adenocarcinoma cell. Cancer Research. 45: 2308-13. PMID 3986774  0.05
2013 Rick FG, Block NL, Schally AV. An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer. Oncotargets and Therapy. 6: 391-402. PMID 23620672 DOI: 10.2147/OTT.S32426  0.05
2013 Lucas R, Czikora I, Sridhar S, Zemskov E, Gorshkov B, Siddaramappa U, Oseghale A, Lawson J, Verin A, Rick FG, Block NL, Pillich H, Romero M, Leustik M, Schally AV, et al. Mini-review: novel therapeutic strategies to blunt actions of pneumolysin in the lungs. Toxins. 5: 1244-60. PMID 23860351 DOI: 10.3390/toxins5071244  0.05
2010 Siejka A, Schally AV, Block NL, Barabutis N. Antagonists of growth hormone-releasing hormone inhibit the proliferation of human benign prostatic hyperplasia cells. The Prostate. 70: 1087-93. PMID 20232355 DOI: 10.1002/pros.21142  0.05
2013 Rick FG, Abi-Chaker A, Szalontay L, Perez R, Jaszberenyi M, Jayakumar AR, Shamaladevi N, Szepeshazi K, Vidaurre I, Halmos G, Krishan A, Block NL, Schally AV. Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist. Proceedings of the National Academy of Sciences of the United States of America. 110: 2617-22. PMID 23359692 DOI: 10.1073/Pnas.1222355110  0.05
2014 Mezey G, Treszl A, Schally AV, Block NL, Vízkeleti L, Juhász A, Klekner A, Nagy J, Balázs M, Halmos G, Bognár L. Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes. Journal of Cancer Research and Clinical Oncology. 140: 1641-9. PMID 24878932 DOI: 10.1007/s00432-014-1716-1  0.05
2012 Rick FG, Schally AV, Szalontay L, Block NL, Szepeshazi K, Nadji M, Zarandi M, Hohla F, Buchholz S, Seitz S. Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases. Proceedings of the National Academy of Sciences of the United States of America. 109: 1655-60. PMID 22307626 DOI: 10.1073/pnas.1120588109  0.049
2013 Rick FG, Saadat SH, Szalontay L, Block NL, Kazzazi A, Djavan B, Schally AV. Hormonal manipulation of benign prostatic hyperplasia. Current Opinion in Urology. 23: 17-24. PMID 23202285 DOI: 10.1097/MOU.0b013e32835abd18  0.049
2013 Rick FG, Schally AV, Block NL, Abi-Chaker A, Krishan A, Szalontay L. Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia. The Prostate. 73: 873-83. PMID 23280565 DOI: 10.1002/pros.22633  0.048
1972 Block NL, Weber D, Schinella R. Blue nevi and other melanotic lesions of the prostate: report of 3 cases and review of the literature. The Journal of Urology. 107: 85-7. PMID 5058047  0.048
2015 Catanuto P, Tashiro J, Rick FG, Sanchez P, Solorzano CC, Glassberg MK, Block NL, Lew JI, Elliot SJ, Schally AV. Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2. Hormones & Cancer. 6: 100-6. PMID 25752763 DOI: 10.1007/s12672-015-0217-2  0.047
2015 Balyura M, Gelfgat E, Ehrhart-Bornstein M, Ludwig B, Gendler Z, Barkai U, Zimerman B, Rotem A, Block NL, Schally AV, Bornstein SR. Transplantation of bovine adrenocortical cells encapsulated in alginate. Proceedings of the National Academy of Sciences of the United States of America. 112: 2527-32. PMID 25675525 DOI: 10.1073/pnas.1500242112  0.047
2011 Schmid J, Ludwig B, Schally AV, Steffen A, Ziegler CG, Block NL, Koutmani Y, Brendel MD, Karalis KP, Simeonovic CJ, Licinio J, Ehrhart-Bornstein M, Bornstein SR. Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11beta-hydroxysteroid dehydrogenase. Proceedings of the National Academy of Sciences of the United States of America. 108: 13722-7. PMID 21825133 DOI: 10.1073/pnas.1110965108  0.047
1980 Malinin TI, Claflin AJ, Block NL, Brown AL. Establishment of primary cell cultures from normal and neoplastic human prostate gland tissue. Progress in Clinical and Biological Research. 37: 161-80. PMID 6155670  0.047
1994 Hurkadli KS, Lokeshwar B, Sheth AR, Block NL. Detection of prostatic-inhibin-like peptide in the cytoplasm of LNCaP cells, a human prostatic adenocarcinoma cell line. The Prostate. 24: 285-90. PMID 8208622 DOI: 10.1002/pros.2990240603  0.046
2012 Szalontay L, Benveniste RJ, Schally AV, Vidaurre I, Nadji M, Zarandi M, Block NL, Kovacs M. Inhibitory effects of GHRH antagonists on human GH-secreting adenoma tissue. Neuroendocrinology. 96: 81-8. PMID 22377963 DOI: 10.1159/000335989  0.046
2016 Shinagawa S, Catindig JA, Block NR, Miller BL, Rankin KP. When a Little Knowledge Can Be Dangerous: False-Positive Diagnosis of Behavioral Variant Frontotemporal Dementia among Community Clinicians. Dementia and Geriatric Cognitive Disorders. 41: 99-108. PMID 26741499 DOI: 10.1159/000438454  0.046
1985 Pollack A, Block NL, Stover BJ, Irvin GL. Tumor progression in serial passages of the Dunning R3327-G rat prostatic adenocarcinoma: growth rate response to endocrine manipulation. Cancer Research. 45: 1052-7. PMID 3971360  0.046
2015 Block NR, Sha SJ, Karydas AM, Fong JC, De May MG, Miller BL, Rosen HJ. Frontotemporal Dementia and Psychiatric Illness: Emerging Clinical and Biological Links in Gene Carriers. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 26324540 DOI: 10.1016/j.jagp.2015.04.007  0.046
1981 Pollack A, Bagwell CB, Block NL, Irvin GL, Claflin AJ, Stover BJ. Flow cytometric analysis of the response of the R3327-G rat prostatic adenocarcinoma to endocrine manipulation. Journal of Surgical Oncology. 18: 389-98. PMID 7321568  0.044
1996 Lokeshwar VB, Lokeshwar BL, Pham HT, Block NL. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Research. 56: 651-7. PMID 8564986  0.044
2013 Jaszberenyi M, Schally AV, Block NL, Zarandi M, Cai RZ, Vidaurre I, Szalontay L, Jayakumar AR, Rick FG. Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro. Targeted Oncology. 8: 281-90. PMID 23371031 DOI: 10.1007/s11523-013-0264-y  0.044
1983 Pollack A, Block NL, Stover BJ, Irvin GL, Fuentes MP, Claflin AJ, Malinin TI. In vivo selection of androgen-insensitive cells in R3327-G rat prostate tumors: diethylstilbestrol diphosphate treatment versus orchiectomy. Journal of the National Cancer Institute. 70: 907-14. PMID 6573535  0.043
2013 Treszl A, Steiber Z, Schally AV, Block NL, Dezso B, Olah G, Rozsa B, Fodor K, Buglyo A, Gardi J, Berta A, Halmos G. Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma. Oncotarget. 4: 1721-8. PMID 24077773  0.043
2010 Barabutis N, Siejka A, Schally AV, Block NL, Cai R, Varga JL. Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor. Journal of Molecular Endocrinology. 44: 127-34. PMID 19897610 DOI: 10.1677/JME-09-0121  0.043
2011 Kiaris H, Block NL, Papavassiliou AG, Schally AV. GHRH and wound healing. Communicative & Integrative Biology. 4: 82-3. PMID 21509187 DOI: 10.4161/cib.4.1.14002  0.043
1996 Block JL, Block NL, Lokeshwar BL. Inhibition of aromatase activity and growth suppression by 4-methoxy-4-androstene-3,17-dione in an androgen sensitive human prostatic carcinoma cell line. Cancer Letters. 101: 143-8. PMID 8620462 DOI: 10.1016/0304-3835(96)04127-4  0.043
2010 Ludwig B, Ziegler CG, Schally AV, Richter C, Steffen A, Jabs N, Funk RH, Brendel MD, Block NL, Ehrhart-Bornstein M, Bornstein SR. Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets. Proceedings of the National Academy of Sciences of the United States of America. 107: 12623-8. PMID 20616039 DOI: 10.1073/pnas.1005098107  0.043
1978 Block NL, Camuzzi F, Stover B, Claflin A, Troner M, Politano VA. Further experience with chemotherapy in the Dunning prostatic adenocarcinoma. Transactions of the American Association of Genito-Urinary Surgeons. 70: 57-9. PMID 753023  0.043
1996 Block JL, Block NL, Lokeshwar BL. Modulation of aromatase activity by growth factors in an androgen sensitive human prostate cancer cell line, LNCaP. Cancer Letters. 102: 167-72. PMID 8603365 DOI: 10.1016/0304-3835(96)04176-6  0.043
2010 Szepeshazi K, Block NL, Schally AV. The use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancers. Hormone Molecular Biology and Clinical Investigation. 1: 103-10. PMID 25961976 DOI: 10.1515/HMBCI.2010.018  0.043
2013 Szepeshazi K, Schally AV, Block NL, Halmos G, Nadji M, Szalontay L, Vidaurre I, Abi-Chaker A, Rick FG. Powerful inhibition of experimental human pancreatic cancers by receptor targeted cytotoxic LH-RH analog AEZS-108. Oncotarget. 4: 751-60. PMID 23744510  0.043
2011 Schally AV, Engel JB, Emons G, Block NL, Pinski J. Use of analogs of peptide hormones conjugated to cytotoxic radicals for chemotherapy targeted to receptors on tumors. Current Drug Delivery. 8: 11-25. PMID 21034424 DOI: 10.2174/156720111793663598  0.042
2012 Szepeshazi K, Schally AV, Rick FG, Block NL, Vidaurre I, Halmos G, Szalontay L. Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-II. Anti-Cancer Drugs. 23: 906-13. PMID 22926257 DOI: 10.1097/CAD.0b013e328354bd25  0.042
2016 Deivaraju C, Temple HT, Block N, Robinson P, Schally AV. LHRH receptor expression in sarcomas of bone and soft tissue. Hormone Molecular Biology and Clinical Investigation. PMID 27639272 DOI: 10.1515/hmbci-2016-0001  0.042
2015 Cohen JK, Santos GM, Moss NJ, Coffin PO, Block N, Klausner JD. Regular clinic attendance in two large San Francisco HIV primary care settings. Aids Care. 1-6. PMID 26654093 DOI: 10.1080/09540121.2015.1118431  0.042
2015 Block N. The canberra plan neglects ground Qualia and Mental Causation in a Physical World: Themes From the Philosophy of Jaegwon Kim. 105-133. DOI: 10.1017/CBO9781139939539.006  0.042
1993 Smith TH, Block NE, Rhodes SJ, Konieczny SF, Miller JB. A unique pattern of expression of the four muscle regulatory factor proteins distinguishes somitic from embryonic, fetal and newborn mouse myogenic cells. Development (Cambridge, England). 117: 1125-33. PMID 8391976  0.042
2015 Block NL, Goodman SM, Hackett SJ, Bates JM, Raherilalao MJ. Potential merger of ancient lineages in a passerine bird discovered based on evidence from host-specific ectoparasites Ecology and Evolution. DOI: 10.1002/ece3.1639  0.042
2012 Lucas R, Sridhar S, Rick FG, Gorshkov B, Umapathy NS, Yang G, Oseghale A, Verin AD, Chakraborty T, Matthay MA, Zemskov EA, White R, Block NL, Schally AV. Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema. Proceedings of the National Academy of Sciences of the United States of America. 109: 2084-9. PMID 22308467 DOI: 10.1073/pnas.1121075109  0.042
2012 Ludwig B, Rotem A, Schmid J, Weir GC, Colton CK, Brendel MD, Neufeld T, Block NL, Yavriyants K, Steffen A, Ludwig S, Chavakis T, Reichel A, Azarov D, Zimermann B, et al. Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proceedings of the National Academy of Sciences of the United States of America. 109: 5022-7. PMID 22393012 DOI: 10.1073/Pnas.1201868109  0.042
2015 Mackrides N, Ganjei-Azar P, Perez R, Cui T, Block N, Schally AV, Nadji M. GHRH Receptor Expression in Malignant Mixed Müllerian Tumors: A Potentially Targetable Biopredictor. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. PMID 26535981 DOI: 10.1097/Pgp.0000000000000229  0.042
2002 Jorda M, Morales A, Ghorab Z, Fernandez G, Nadji M, Block N. Her2 expression in prostatic cancer: a comparison with mammary carcinoma. The Journal of Urology. 168: 1412-4. PMID 12352406 DOI: 10.1097/01.ju.0000030159.27410.38  0.041
2013 Jaszberenyi M, Schally AV, Block NL, Nadji M, Vidaurre I, Szalontay L, Rick FG. Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone. Oncotarget. 4: 422-32. PMID 23518876  0.041
1997 Pham HT, Block NL, Lokeshwar VB. Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer. Cancer Research. 57: 778-83. PMID 9044860  0.041
1994 Gkonos PJ, Kwok CK, Block NL, Roos BA. Identification of the human seminal TRH-like peptide pGlu-Phe-Pro-NH2 in normal human prostate. Peptides. 15: 1281-3. PMID 7854981 DOI: 10.1016/0196-9781(94)90154-6  0.04
1982 Pollack A, Irvin GL, Block NL, Lipton RM, Stover BJ, Claflin AJ. Hormone sensitivity of the R3327-G rat prostate adenocarcinoma: growth rate, DNA content, and hormone receptors. Cancer Research. 42: 2184-90. PMID 7074599  0.04
1999 Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 8: 241-8. PMID 10090302  0.04
1993 Lokeshwar BL, Hurkadli KS, Sheth AR, Block NL. Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor. Cancer Research. 53: 4855-9. PMID 8402673  0.04
2015 Zhang X, Cui T, He J, Wang H, Cai R, Popovics P, Vidaurre I, Sha W, Schmid J, Ludwig B, Block NL, Bornstein SR, Schally AV. Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 26474831 DOI: 10.1073/pnas.1518540112  0.04
2014 Czikora I, Sridhar S, Gorshkov B, Alieva IB, Kasa A, Gonzales J, Potapenko O, Umapathy NS, Pillich H, Rick FG, Block NL, Verin AD, Chakraborty T, Matthay MA, Schally AV, et al. Protective effect of Growth Hormone-Releasing Hormone agonist in bacterial toxin-induced pulmonary barrier dysfunction. Frontiers in Physiology. 5: 259. PMID 25076911 DOI: 10.3389/fphys.2014.00259  0.04
2012 Klukovits A, Schally AV, Szalontay L, Vidaurre I, Papadia A, Zarandi M, Varga JL, Block NL, Halmos G. Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers. Cancer. 118: 670-80. PMID 21751186 DOI: 10.1002/cncr.26291  0.039
2011 Goodman SM, Raherilalao MJ, Block NL. Patterns of morphological and genetic variation in the Mentocrex kioloides complex (Aves: Gruiformes: Rallidae) from Madagascar, with the description of a new species Zootaxa. 49-60. DOI: 10.11646/Zootaxa.2776.1.3  0.039
2010 Siejka A, Schally AV, Block NL, Barabutis N. Mechanisms of inhibition of human benign prostatic hyperplasia in vitro by the luteinizing hormone-releasing hormone antagonist cetrorelix. Bju International. 106: 1382-8. PMID 20151966 DOI: 10.1111/j.1464-410X.2010.09215.x  0.039
2014 Hohla F, Winder T, Greil R, Rick FG, Block NL, Schally AV. Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectives. World Journal of Gastroenterology : Wjg. 20: 6102-12. PMID 24876732 DOI: 10.3748/wjg.v20.i20.6102  0.039
2013 Ludwig B, Reichel A, Steffen A, Zimerman B, Schally AV, Block NL, Colton CK, Ludwig S, Kersting S, Bonifacio E, Solimena M, Gendler Z, Rotem A, Barkai U, Bornstein SR. Transplantation of human islets without immunosuppression. Proceedings of the National Academy of Sciences of the United States of America. 110: 19054-8. PMID 24167261 DOI: 10.1073/Pnas.1317561110  0.039
2010 Kanashiro-Takeuchi RM, Tziomalos K, Takeuchi LM, Treuer AV, Lamirault G, Dulce R, Hurtado M, Song Y, Block NL, Rick F, Klukovits A, Hu Q, Varga JL, Schally AV, Hare JM. Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America. 107: 2604-9. PMID 20133784 DOI: 10.1073/pnas.0914138107  0.039
1984 Pollack A, Block NL, Stover BJ, Fuentes MP, Irvin GL. Effects of the gonadotropin-releasing hormone agonist [D-leu6, desgly-NH2(10), proethylamide9]-GnRH (leuprolide) on R3327-G rat prostatic tumor growth. The Journal of Urology. 131: 399-403. PMID 6422059  0.038
2012 Kanashiro-Takeuchi RM, Takeuchi LM, Rick FG, Dulce R, Treuer AV, Florea V, Rodrigues CO, Paulino EC, Hatzistergos KE, Selem SM, Gonzalez DR, Block NL, Schally AV, Hare JM. Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI). Proceedings of the National Academy of Sciences of the United States of America. 109: 559-63. PMID 22203988 DOI: 10.1073/pnas.1119203109  0.038
1971 Block NL, Hotchkiss RS. Malignant melanoma of the female urethra: report of a case with 5-year survival and review of the literature. The Journal of Urology. 105: 251-5. PMID 5090370  0.038
2001 Lokeshwar VB, Rubinowicz D, Schroeder GL, Forgacs E, Minna JD, Block NL, Nadji M, Lokeshwar BL. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. The Journal of Biological Chemistry. 276: 11922-32. PMID 11278412 DOI: 10.1074/jbc.M008432200  0.038
1995 Andriole G, Lieber M, Smith J, Soloway M, Schroeder F, Kadmon D, Dekernion J, Rajfer J, Boake R, Crawford D, Ramsey E, Perreault J, Trachtenberg J, Fradet Y, Block N, et al. Treatment with finasteride following radical prostatectomy for prostate cancer Urology. 45: 491-497. PMID 7533461 DOI: 10.1016/S0090-4295(99)80021-1  0.038
2005 Block NR, Introne RE, Schott JR. Using multispectral information to decrease the spectral artifacts in sparse-aperture imagery Proceedings of Spie - the International Society For Optical Engineering. 5798: 139-150. DOI: 10.1117/12.604002  0.037
1997 Schellhammer PF, Sharifi R, Block NL, Soloway MS, Venner PM, Patterson AL, Sarosdy MF, Vogelzang NJ, Schellenger JJ, Kolvenbag GJ. Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study Group. Urology. 50: 330-6. PMID 9301693 DOI: 10.1016/S0090-4295(97)00279-3  0.037
1992 Block NE, Miller JB. Expression of MRF4, a myogenic helix-loop-helix protein, produces multiple changes in the myogenic program of BC3H-1 cells. Molecular and Cellular Biology. 12: 2484-92. PMID 1588952  0.037
2012 Szepeshazi K, Schally AV, Keller G, Block NL, Benten D, Halmos G, Szalontay L, Vidaurre I, Jaszberenyi M, Rick FG. Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 [AEZS- 108]. Oncotarget. 3: 686-99. PMID 22824624  0.037
2015 Schally AV, Perez R, Block NL, Rick FG. Potentiating effects of GHRH analogs on the response to chemotherapy. Cell Cycle (Georgetown, Tex.). 14: 699-704. PMID 25648497 DOI: 10.1080/15384101.2015.1010893  0.036
2015 Kanashiro-Takeuchi RM, Szalontay L, Schally AV, Takeuchi LM, Popovics P, Jaszberenyi M, Vidaurre I, Zarandi M, Cai RZ, Block NL, Hare JM, Rick FG. New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor. Oncotarget. 6: 9728-39. PMID 25797248  0.036
1986 Ghandur-Mnaymneh L, Satterfield S, Block NL. Small cell carcinoma of the prostate gland with inappropriate antidiuretic hormone secretion: morphological, immunohistochemical and clinical expressions. The Journal of Urology. 135: 1263-6. PMID 2423710  0.036
2012 Rick FG, Szalontay L, Schally AV, Block NL, Nadji M, Szepeshazi K, Vidaurre I, Zarandi M, Kovacs M, Rekasi Z. Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage. The Journal of Urology. 187: 1498-504. PMID 22341819 DOI: 10.1016/j.juro.2011.11.081  0.036
1988 Malinin TI, Hornicek FJ, Block NL, Malinin GI. Aneuploidy of glandular epithelial cells in histologically normal prostate glands. Experientia. 44: 247-9. PMID 3350136 DOI: 10.1007/BF01941724  0.035
1995 Schellhammer P, Sharifi R, Block N, Soloway M, Venner P, Patterson AL, Sarosdy M, Vogelzang N, Jones J, Kolvenbag G. A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study Group. Urology. 45: 745-52. PMID 7538237 DOI: 10.1016/S0090-4295(99)80077-6  0.035
2013 Kanczkowski W, Alexaki VI, Tran N, Großklaus S, Zacharowski K, Martinez A, Popovics P, Block NL, Chavakis T, Schally AV, Bornstein SR. Hypothalamo-pituitary and immune-dependent adrenal regulation during systemic inflammation. Proceedings of the National Academy of Sciences of the United States of America. 110: 14801-6. PMID 23959899 DOI: 10.1073/pnas.1313945110  0.035
2010 Eissa SS, Block N, Khaled HM, Shoman SH, Nassiri M, Nadji M. Primary enteric-type adenocarcinomas of the urinary bladder are histogenetically analogous to colorectal carcinomas: Immunohistochemical evaluation of 109 cases Journal of Advanced Research. 1: 151-156. DOI: 10.1016/j.jare.2010.03.006  0.035
1998 Lokeshwar VB, Soloway MS, Block NL. Secretion of bladder tumor-derived hyaluronidase activity by invasive bladder tumor cells. Cancer Letters. 131: 21-7. PMID 9839616 DOI: 10.1016/S0304-3835(98)00197-9  0.035
2014 Florea V, Majid SS, Kanashiro-Takeuchi RM, Cai RZ, Block NL, Schally AV, Hare JM, Rodrigues CO. Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival. Proceedings of the National Academy of Sciences of the United States of America. 111: 17260-5. PMID 25404316 DOI: 10.1073/pnas.1420375111  0.035
1980 Shessel FS, Block NL, Stover B, Claflin A, Malinin TI, Politano VA. Endocrine manipulation of the Dunning prostatic adenocarcinoma. Investigative Urology. 17: 529-33. PMID 7372443  0.035
2002 Lokeshwar BL, Selzer MG, Zhu BQ, Block NL, Golub LM. Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model. International Journal of Cancer. Journal International Du Cancer. 98: 297-309. PMID 11857423 DOI: 10.1002/ijc.10168  0.035
1996 Schellhammer PF, Sharifi R, Block NL, Soloway MS, Venner PM, Patterson AL, Sarosdy MF, Vogelzang NJ, Chen Y, Kolvenbag GJ. A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study Group. Cancer. 78: 2164-9. PMID 8918410 DOI: 10.1002/(SICI)1097-0142(19961115)78:10<2164::AID-CNCR18>3.0.CO;2-X  0.035
2013 Schally AV, Engel JB, Pinski J, Block NL. LHRH Analogs Handbook of Biologically Active Peptides. 531-540. DOI: 10.1016/B978-0-12-385095-9.00073-7  0.035
2012 Petronilho F, Vuolo F, Galant LS, Constantino L, Tomasi CD, Giombelli VR, de Souza CT, da Silva S, Barbeiro DF, Soriano FG, Streck EL, Ritter C, Zanotto-Filho A, Pasquali MA, Gelain DP, ... ... Block NL, et al. Gastrin-releasing peptide receptor antagonism induces protection from lethal sepsis: involvement of toll-like receptor 4 signaling. Molecular Medicine (Cambridge, Mass.). 18: 1209-19. PMID 22735756 DOI: 10.2119/Molmed.2012.00083  0.035
1995 Lokeshwar BL, Lokeshwar VB, Block NL. Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential. Anticancer Research. 15: 1191-8. PMID 7544562  0.034
1974 Machiz S, Gordon J, Block N, Politano VA. Salmonella typhosa urinary tract infection and xanthogranulomatous pyelonephritis. Case report and review of literature. The Journal of the Florida Medical Association. 61: 703-5. PMID 4854191  0.034
1974 Dowlen LW, Block NL, Politano VA. Complications of transrectal biopsy examination of the prostate. Southern Medical Journal. 67: 1453-6. PMID 4547859  0.034
2012 Buchholz S, Seitz S, Engel JB, Montero A, Ortmann O, Perez R, Block NL, Schally AV. Search for novel therapies for triple negative breast cancers (TNBC): analogs of luteinizing hormone-releasing hormone (LHRH) and growth hormone-releasing hormone (GHRH). Hormone Molecular Biology and Clinical Investigation. 9: 87-94. PMID 25961354 DOI: 10.1515/Hmbci-2011-0002  0.034
1998 Lokeshwar BL, Houston-Clark HL, Selzer MG, Block NL, Golub LM. Potential application of a chemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer. Advances in Dental Research. 12: 97-102. PMID 1999125161  0.034
1998 Lokeshwar BL, Houston-Clark HL, Selzer MG, Block NL, Golub LM. Potential application of a chemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer. Advances in Dental Research. 12: 97-102. PMID 9972130  0.034
1996 Schellhammer P, Sharifi R, Block N, Soloway M, Venner P, Patterson AL, Sarosdy M, Vogelzang N, Jones J, Kolvenbag G. Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group. Urology. 47: 54-60; discussion 80. PMID 8560679  0.034
2014 Qin YJ, Chan SO, Chong KK, Li BF, Ng TK, Yip YW, Chen H, Zhang M, Block NL, Cheung HS, Schally AV, Pang CP. Antagonist of GH-releasing hormone receptors alleviates experimental ocular inflammation. Proceedings of the National Academy of Sciences of the United States of America. 111: 18303-8. PMID 25489106 DOI: 10.1073/Pnas.1421815112  0.034
2010 Schally AV, Block NL. Luteinizing hormone-releasing hormone and its agonistic, antagonistic, and targeted cytotoxic analogs in prostate cancer Drug Management of Prostate Cancer. 27-39. DOI: 10.1007/978-1-60327-829-4_2  0.034
2011 Rozsa B, Nadji M, Schally AV, Dezso B, Flasko T, Toth G, Mile M, Block NL, Halmos G. Receptors for luteinizing hormone-releasing hormone (LHRH) in benign prostatic hyperplasia (BPH) as potential molecular targets for therapy with LHRH antagonist cetrorelix. The Prostate. 71: 445-52. PMID 20859992 DOI: 10.1002/pros.21258  0.034
1978 Claflin AJ, Vesely DL, Hudson JL, Bagwell CB, Lehotay DC, Lo TM, Fletcher MA, Block NL, Levey GS. Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata). Proceedings of the National Academy of Sciences of the United States of America. 75: 989-93. PMID 24847 DOI: 10.1073/pnas.75.2.989  0.033
1995 Vogelzang NJ, Chodak GW, Soloway MS, Block NL, Schellhammer PF, Smith JA, Caplan RJ, Kennealey GT. Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study Group. Urology. 46: 220-6. PMID 7624991 DOI: 10.1016/S0090-4295(99)80197-6  0.033
2014 Fernandez-Castro G, Schally AV, Koru-Sengu T, Jorda M, Merchan JR, Flores AM, Restrepo M, Block NL. Single case of a complete response in a metastatic urothelial carcinoma patient treated with zoptarelin doxorubicin European Oncology and Haematology. 10.  0.033
1992 Bloch WE, Block NL. Metastatic prostate cancer presenting as obstructive jaundice. Urology. 40: 456-7. PMID 1441046 DOI: 10.1016/0090-4295(92)90464-8  0.033
2014 Chatzigeorgiou A, Seijkens T, Zarzycka B, Engel D, Poggi M, Van Den Berg S, Soehnlein O, Winkels H, Beckers L, Lievens D, Driessen A, Kusters P, Biessen E, Garcia-Martin R, Ameln AKV, ... ... Block NL, et al. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (Proceedings of the National Academy of Sciences of the United States of America (2014) 111, 7 (2686-2691) DOI: 10.1073/pnas.1400419111) Proceedings of the National Academy of Sciences of the United States of America. 111: 4644. DOI: 10.1073/Pnas.1403231111  0.033
2011 Rick FG, Schally AV, Block NL, Halmos G, Perez R, Fernandez JB, Vidaurre I, Szalontay L. LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia. The Prostate. 71: 736-47. PMID 20945403 DOI: 10.1002/Pros.21289  0.033
2012 Rick FG, Buchholz S, Schally AV, Szalontay L, Krishan A, Datz C, Stadlmayr A, Aigner E, Perez R, Seitz S, Block NL, Hohla F. Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers. Cell Cycle (Georgetown, Tex.). 11: 2518-25. PMID 22751419 DOI: 10.4161/Cc.20900  0.033
2012 Rick FG, Seitz S, Schally AV, Szalontay L, Krishan A, Datz C, Stadlmayr A, Buchholz S, Block NL, Hohla F. GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer. Cell Cycle (Georgetown, Tex.). 11: 4203-10. PMID 23095641 DOI: 10.4161/cc.22498  0.033
2013 Rick FG, Block NL, Schally AV. Re: editorial comment on LHRH antagonist cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia (Prostate 2011; 71: 736-747). The Journal of Urology. 189: 1604-5. PMID 23103799 DOI: 10.1016/j.juro.2012.10.062  0.032
1999 McLeod DG, Schellhammer PF, Vogelzang NJ, Soloway MS, Sharifi R, Block NL, Venner PM, Patterson AL, Sarosdy MF, Kelley RP, Kolvenbag GJ. Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study Group. The Prostate. 40: 218-24. PMID 10420149 DOI: 10.1002/(SICI)1097-0045(19990901)40:4<218::AID-PROS2>3.0.CO;2-6  0.032
1998 Schellhammer PF, Sharifi R, Block NL, Soloway MS, Venner PM, Patterson AL, Sarosdy MF, Vogelzang NJ, Schellenger JJ, Kolvenbag GJCM. Erattum: Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: Final report of a double-blind, randomized, multicenter trial (Urology (September 1997) 50 (330-336)) Urology. 51: 352. DOI: 10.1016/S0090-4295(98)00091-0  0.032
2014 Cai R, Schally AV, Cui T, Szalontay L, Halmos G, Sha W, Kovacs M, Jaszberenyi M, He J, Rick FG, Popovics P, Kanashiro-Takeuchi R, Hare JM, Block NL, Zarandi M. Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities. Peptides. 52: 104-12. PMID 24373935 DOI: 10.1016/j.peptides.2013.12.010  0.032
1991 Soloway MS, Chodak G, Vogelzang NJ, Block NL, Schellhammer PF, Smith JA, Scott M, Kennealey G, Gau TC. Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study Group. Urology. 37: 46-51. PMID 1824732 DOI: 10.1016/0090-4295(91)80077-K  0.032
2001 Block N. Behaviorism revisited Behavioral and Brain Sciences. 24: 977-978.  0.031
2011 Schmid J, Ludwig B, Schally AV, Steffen A, Ziegler CG, Block NL, Koutmani Y, Brendel MD, Karalis KP, Simeonovic CJ, Licinio J, Ehrhart-Bornstein M, Bornstein SR. Reply to Liu et al.: Hypothalamic control of islets Proceedings of the National Academy of Sciences of the United States of America. 108: E1391. DOI: 10.1073/pnas.1117006109  0.031
1993 Miller JB, Everitt EA, Smith TH, Block NE, Dominov JA. Cellular and molecular diversity in skeletal muscle development: news from in vitro and in vivo. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 15: 191-6. PMID 8387785 DOI: 10.1002/bies.950150308  0.031
1993 Gkonos PJ, Kwok CK, Block NL, Roos BA. Expression of prostatic TRH-like peptides differs between species and between malignant and nonmalignant tissues. The Prostate. 23: 135-47. PMID 7690955  0.031
2009 Sfakianakis GN, Sfakianaki E, Georgiou M, Serafini A, Ezuddin S, Kuker R, Zilleruelo G, Strauss J, Abitbol C, Chandar J, Seeherunvong W, Bourgoignie J, Roth D, Leveillee R, Bird VG, ... Block N, et al. A renal protocol for all ages and all indications: mercapto-acetyl-triglycine (MAG3) with simultaneous injection of furosemide (MAG3-F0): a 17-year experience. Seminars in Nuclear Medicine. 39: 156-73. PMID 19341836 DOI: 10.1053/j.semnuclmed.2008.11.001  0.031
2012 Perez R, Schally AV, Vidaurre I, Rincon R, Block NL, Rick FG. Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers. Oncotarget. 3: 988-97. PMID 22941871 DOI: 10.18632/Oncotarget.634  0.031
1992 Lokeshwar BL, Block NL. Isolation of a prostate carcinoma cell proliferation-inhibiting factor from human seminal plasma and its similarity to transforming growth factor beta. Cancer Research. 52: 5821-5. PMID 1394210  0.031
1979 Charyulu K, Block N, Sudarsanam A. Preoperative extended field radiation with I-125 seed implant in prostatic cancer: a preliminary report of a randomized study. International Journal of Radiation Oncology, Biology, Physics. 5: 1957-61. PMID 544574 DOI: 10.1016/0360-3016(79)90945-3  0.03
1997 Block N, McCormick KF. Nonviolent Childhood Discipline Journal of Aggression, Maltreatment and Trauma. 1: 179-206.  0.03
1983 Reese DH, Gordon B, Gratzner HG, Claflin AJ, Malinin TI, Block NL, Politano VA. Effect of retinoic acid on the growth and morphology of a prostatic adenocarcinoma cell line cloned for the retinoid inducibility of alkaline phosphatase. Cancer Research. 43: 5443-50. PMID 6616477  0.03
1997 Klotz LH, Sogani PC, Block NL. Summary of intermittent endocrine therapy for advanced prostate cancer (by Laurence H. Klotz, MD, Harry W. Herr, MD, Michael J. Morse, MD, and Willet F. Whitmore, Jr, MD). 1986. Seminars in Urologic Oncology. 15: 117-22. PMID 9134606  0.03
1995 Block NL, Ciancio G. Conservative surgical treatment of renal cell carcinoma. The University of Miami experience. The Journal of the Florida Medical Association. 82: 607-11. PMID 7595342  0.029
1998 Lokeshawar VB, Selzer MG, Block NL. Hyaluronic acid functions and signalling in endothelia of different origins Faseb Journal. 12: A957.  0.029
1999 Selzer MG, Zhu B, Block NL, Lokeshwar BL. CMT-3, a chemically modified tetracycline, inhibits bony metastases and delays the development of paraplegia in a rat model of prostate cancer. Annals of the New York Academy of Sciences. 878: 678-82. PMID 10415806 DOI: 10.1111/j.1749-6632.1999.tb07760.x  0.029
2000 Lokeshwar VB, Block NL. HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade. The Urologic Clinics of North America. 27: 53-61. PMID 10696245 DOI: 10.1016/S0094-0143(05)70234-2  0.029
2012 Dioufa N, Farmaki E, Schally AV, Kiaris H, Vlahodimitropoulos D, Papavassiliou AG, Kittas C, Block NL, Chatzistamou I. Growth hormone-releasing hormone receptor splice variant 1 is frequently expressed in oral squamous cell carcinomas. Hormones & Cancer. 3: 172-80. PMID 22441816 DOI: 10.1007/s12672-012-0108-8  0.028
1980 Camuzzi F, Block NL, Stover B, Gottlieb C, Charyulu K, Politano VA. Investigation of different combinations of estrogen therapy and radiation therapy on prostatic adenocarcinoma (R-3327). Urology. 15: 443-7. PMID 7052707 DOI: 10.1016/0090-4295(80)90002-3  0.028
1997 Lokeshwar VB, Obek C, Soloway MS, Block NL. Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Research. 57: 773-7. PMID 9044859  0.028
1996 Dudak SD, Lopez A, Block NL, Lokeshwar BL. Enhancement of radiation response of prostatic carcinoma by lonidamine. Anticancer Research. 16: 3665-71. PMID 9042239  0.028
2013 Schubert U, Schmid J, Lehmann S, Zhang XY, Morawietz H, Block NL, Kanczkowski W, Schally AV, Bornstein SR, Ludwig B. Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone. Proceedings of the National Academy of Sciences of the United States of America. 110: 2288-93. PMID 23345449 DOI: 10.1073/pnas.1221505110  0.028
1994 Bloch WE, Lokeshwar BL, Ferrell SM, Block NL. Enhancement of hyperthermic toxicity by lonidamine in the Dunning R3327G rat prostatic adenocarcinoma. The Prostate. 24: 131-8. PMID 8115278  0.028
1978 Radomski JL, Greenwald D, Hearn WL, Block NL, Woods FM. Nitrosamine formation in bladder infections and its role in the etiology of bladder cancer. The Journal of Urology. 120: 48-50. PMID 671604  0.028
1981 Camuzzi FA, Block NL, Charyulu K, Thomsen S, Politano VA. Leiomyosarcoma of prostate gland. Urology. 18: 295-7. PMID 7281399 DOI: 10.1016/0090-4295(81)90370-8  0.027
2009 Rózsa B, Juhász A, Treszl A, Tóth G, Flaskó T, Dezsö B, Block NL, Schally AV, Halmos G. Expression of mRNA for human type-I LHRH receptor transcript forms in human benign prostatic hyperplasia. International Journal of Oncology. 35: 1053-9. PMID 19787259 DOI: 10.3892/ijo-00000420  0.027
2010 Lindholm-Leary K, Block N. Achievement in predominantly low SES/Hispanic dual language schools International Journal of Bilingual Education and Bilingualism. 13: 43-60. DOI: 10.1080/13670050902777546  0.027
1996 Block NE, Zhu Z, Kachinsky AM, Dominov JA, Miller JB. Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 207: 382-94. PMID 8950513 DOI: 10.1002/(SICI)1097-0177(199612)207:4<382::AID-AJA3>3.0.CO;2-D  0.027
2011 Block N. The impact of two-way dual-immersion programs on initially English-dominant Latino students' attitudes Bilingual Research Journal. 34: 125-141. DOI: 10.1080/15235882.2011.598059  0.027
1982 Claflin AJ, Pollack A, Malinin T, Block NL, Irvin GL. Flow cytometric analysis of R3327 rat prostate adenocarcinoma grown in vivo and in vitro. Journal of the National Cancer Institute. 69: 79-87. PMID 6954325  0.026
2000 Soloway MS, Schellhammer PF, Sharifi R, Block NL, Venner PM, Lynn Patterson A, Sarosdy MF, Vogelzang NJ, Schellenger J, Kolvenbag GJCM. Bicalutamide and flutamide, each in combination with luteinizing hormone-releasing hormone analogs, in advanced prostate cancer: Exploratory analysis of impact of extent of disease by bone scan on outcome Prostate Journal. 2: 137-145. DOI: 10.1046/j.1525-1411.2000.23003.x  0.026
2014 Ullrich M, Bergmann R, Peitzsch M, Cartellieri M, Qin N, Ehrhart-Bornstein M, Block NL, Schally AV, Pietzsch J, Eisenhofer G, Bornstein SR, Ziegler CG. In vivo fluorescence imaging and urinary monoamines as surrogate biomarkers of disease progression in a mouse model of pheochromocytoma. Endocrinology. 155: 4149-56. PMID 25137029 DOI: 10.1210/en.2014-1431  0.025
1995 Lokeshwar BL, Ferrell SM, Block NL. Enhancement of radiation response of prostatic carcinoma by taxol: therapeutic potential for late-stage malignancy. Anticancer Research. 15: 93-8. PMID 7733649  0.025
2000 Lokeshwar VB, Obek C, Pham HT, Wei D, Young MJ, Duncan RC, Soloway MS, Block NL. Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade. The Journal of Urology. 163: 348-56. PMID 10604388 DOI: 10.1016/S0022-5347(05)68050-0  0.025
1981 Collins JM, Bagwell CB, Block NL, Claflin AJ, Irvin GL, Pollack A, Stover B. Flow cytometric monitoring of R 3327 rat prostate carcinoma. Investigative Urology. 19: 8-13. PMID 7019155  0.025
1991 Block NE, Komori K, Robinson KA, Dutton SL, Lam CF, Buse MG. Diabetes-associated impairment of hepatic insulin receptor tyrosine kinase activity: a study of mechanisms. Endocrinology. 128: 312-22. PMID 1846101 DOI: 10.1210/endo-128-1-312  0.025
1998 Sarosdy MF, Schellhammer PF, Sharifi R, Block NL, Soloway MS, Venner PM, Patterson AL, Vogelzang NJ, Chodak GW, Klein EA, Schellenger JJ, Kolvenbag GJ. Comparison of goserelin and leuprolide in combined androgen blockade therapy. Urology. 52: 82-8. PMID 9671875 DOI: 10.1016/S0090-4295(98)00145-9  0.025
1995 Chodak G, Sharifi R, Kasimis B, Block NL, Macramalla E, Kennealey GT. Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma. Urology. 46: 849-55. PMID 7502428 DOI: 10.1016/S0090-4295(99)80356-2  0.025
1984 Issell BF, Prout GR, Soloway MS, Cummings KB, Brannen G, Veenema R, Flanagan M, Block NL, Summers JL, Levin EA. Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepa. Cancer. 53: 1025-8. PMID 6420039  0.024
1988 Gottlieb CF, Seibert GB, Block NL. Interaction of irradiation and microwave-induced hyperthermia in the Dunning R3327G prostatic adenocarcinoma model. Radiology. 169: 243-7. PMID 3420266 DOI: 10.1148/radiology.169.1.3420266  0.024
1976 Charyulu KK, Sudarsanam A, Block NL, Houdek P. Role of iodine-125 seeds in interstitial therapy. Panminerva Medica. 18: 34-5. PMID 1246447  0.023
1979 Bagwell CB, Block NL, Irvin GL. Flow cytometric monitoring of prostatic carcinoma. Surgical Forum. 30: 556-7. PMID 395709  0.023
1989 Komori K, Block NE, Robinson KA, Buse MG. Insulin-stimulated phosphorylation of a 195K protein from muscle and liver in the presence of poly-L-lysine. Endocrinology. 125: 1438-50. PMID 2547586 DOI: 10.1210/endo-125-3-1438  0.022
1988 Gottlieb CF, Seibert GB, Block NL. Systematic investigation into interaction of ionizing radiation and doxorubicin in the Dunning R3327G prostatic adenocarcinoma model. Nci Monographs : a Publication of the National Cancer Institute. 147-53. PMID 3352758  0.022
1974 Lankford R, Block NL, Politano VA. Gunshot wounds of the ureter: a review of 10 cases. The Journal of Trauma. 14: 848-52. PMID 4420894  0.022
1986 Pollack A, Moulis H, Prudhomme DL, Block NL, Irvin GL. Flow cytometric analysis of cell kinetic responses using measurements of correlated DNA and nuclear protein. Annals of the New York Academy of Sciences. 468: 55-66. PMID 3089117  0.022
2000 Tilton RG, Munsch CL, Sherwood SJ, Chen SJ, Chen YF, Wu C, Block N, Dixon RA, Brock TA. Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist. Pulmonary Pharmacology & Therapeutics. 13: 87-97. PMID 10799286 DOI: 10.1006/Pupt.2000.0237  0.021
2000 Sfakianakis GN, Cohen DJ, Braunstein RH, Leveillee RJ, Lerner I, Bird VG, Sfakianakis E, Georgiou MF, Block NL, Lynne CM. MAG3-F0 scintigraphy in decision making for emergency intervention in renal colic after helical CT positive for a urolith. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 41: 1813-22. PMID 11079488  0.021
1975 Loor F, Block N, Little RJ. Dynamics of the TL antigens on thymus and leukemia cells. Cellular Immunology. 17: 351-65. PMID 1092479  0.02
2014 Miller ZA, Hinkley LB, Herman A, Honma S, Findlay A, Block N, Ketelle R, Rabinovici G, Rosen H, Nagarajan SS, Miller BL, Gorno-Tempini ML. Clinical/scientific notes Neurology. 84: 204-206.  0.02
2009 Cerwinka WH, Block NL. Civilian gunshot injuries of the penis: the Miami experience. Urology. 73: 877-80. PMID 19193421 DOI: 10.1016/j.urology.2008.10.057  0.02
1988 Irvin GL, Taupier MA, Block NL, Reiss E. DNA patterns in parathyroid disease predict postoperative parathyroid hormone secretion. Surgery. 104: 1115-20. PMID 3194838  0.019
1998 Leveillee RJ, Pinchuk L, Wilson GJ, Block NL. A new self-expanding lined stent-graft in the dog ureter: radiological, gross, histopathological and scanning electron microscopic findings. The Journal of Urology. 160: 1877-82. PMID 9783978 DOI: 10.1016/S0022-5347(01)62436-4  0.019
1984 Pollack A, Moulis H, Block NL, Irvin GL. Quantitation of cell kinetic responses using simultaneous flow cytometric measurements of DNA and nuclear protein. Cytometry. 5: 473-81. PMID 6489061 DOI: 10.1002/cyto.990050507  0.018
1991 Block NE, Komori K, Dutton SL, Robinson KA, Buse MG. Skeletal muscle insulin-receptor kinase. Effects of substrate inhibition and diabetes. Diabetes. 40: 1691-700. PMID 1661694 DOI: 10.2337/diab.40.12.1691  0.018
2015 Engel JB, Tinneberg HR, Block NL, Berkes E, Schally AV. Analogs of luteinizing Hormone-Releasing hormone in the treatment of endometriosis Journal of Endometriosis. 7: 19-26. DOI: 10.5301/je.5000208  0.018
1986 Burant CF, Treutelaar MK, Block NE, Buse MG. Structural differences between liver- and muscle-derived insulin receptors in rats. The Journal of Biological Chemistry. 261: 14361-4. PMID 3533919  0.018
2012 Block NC. Perceived impact of two-way dual immersion programs on Latino students' relationships in their families and communities International Journal of Bilingual Education and Bilingualism. 15: 235-257. DOI: 10.1080/13670050.2011.620079  0.017
1993 Lokeshwar BL, Selzer MG, Block NL, Gunja-Smith Z. Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Research. 53: 4493-8. PMID 7691397  0.017
2010 Dioufa N, Schally AV, Chatzistamou I, Moustou E, Block NL, Owens GK, Papavassiliou AG, Kiaris H. Acceleration of wound healing by growth hormone-releasing hormone and its agonists. Proceedings of the National Academy of Sciences of the United States of America. 107: 18611-5. PMID 20937882 DOI: 10.1073/pnas.1013942107  0.017
1973 Block NL, Rosen P, Whitmore WF. Hemipelvectomy for advanced penile cancer. The Journal of Urology. 110: 703-7. PMID 4757556  0.017
1999 Sample VA, Ringgold PC, Block NE, Giltmier JW. Forestry Education: Adapting to the Changing Demands Journal of Forestry. 97: 4-10.  0.017
1998 Pham HT, Block NL, Lokeshwar VB. Tumor-derived hyaluronidase: A diagnostic urine marker for high-grade bladder cancer Journal of Urology. 160: 619-620. PMID 9679940 DOI: 10.1016/S0022-5347(01)62975-6  0.017
1991 Block NE, Menick DR, Robinson KA, Buse MG. Effect of denervation on the expression of two glucose transporter isoforms in rat hindlimb muscle. The Journal of Clinical Investigation. 88: 1546-52. PMID 1939643 DOI: 10.1172/JCI115465  0.017
1982 Pollack A, Prudhomme DL, Greenstein DB, Irvin GL, Claflin AJ, Block NL. Flow cytometric analysis of RNA content in different cell populations using pyronin Y and methyl green. Cytometry. 3: 28-35. PMID 6180873 DOI: 10.1002/cyto.990030108  0.016
2015 Bagno LL, Kanashiro-Takeuchi RM, Suncion VY, Golpanian S, Karantalis V, Wolf A, Wang B, Premer C, Balkan W, Rodriguez J, Valdes D, Rosado M, Block NL, Goldstein P, Morales A, et al. Growth hormone-releasing hormone agonists reduce myocardial infarct scar in swine with subacute ischemic cardiomyopathy. Journal of the American Heart Association. 4. PMID 25827134 DOI: 10.1161/JAHA.114.001464  0.016
1999 Zhu B, Block NL, Lokeshwar BL. Interaction between stromal cells and tumor cells induces chemoresistance and matrix metalloproteinase secretion. Annals of the New York Academy of Sciences. 878: 642-6. PMID 10415796 DOI: 10.1111/j.1749-6632.1999.tb07750.x  0.016
2009 Katkoori D, Samavedi S, Jorda M, Block NL, Manoharan M. A rare case of renal gastrinoma. Thescientificworldjournal. 9: 501-4. PMID 19578706 DOI: 10.1100/tsw.2009.77  0.015
1981 Wasmer JM, Block NL, Politano VA, Tejada F. Penile angiosarcoma presenting in bladder. Urology. 18: 179-80. PMID 7196635 DOI: 10.1016/0090-4295(81)90434-9  0.015
2006 Block N, Tyrrell M, Gordon E, Franco O. Conservation planning: Considerations for the forest products industry Ncasi Special Report. 37-42.  0.015
2000 Block NE. Credentialing and Accreditation Programs: Taking the Forestry Profession to the Next Level Journal of Forestry. 98: 18-22.  0.015
2014 Chatzigeorgiou A, Seijkens T, Zarzycka B, Engel D, Poggi M, van den Berg S, van den Berg S, Soehnlein O, Winkels H, Beckers L, Lievens D, Driessen A, Kusters P, Biessen E, Garcia-Martin R, ... ... Block NL, et al. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance. Proceedings of the National Academy of Sciences of the United States of America. 111: 2686-91. PMID 24492375 DOI: 10.1073/Pnas.1400419111  0.015
1996 Korman HJ, Watson RB, Civantos F, Block NL, Soloway MS. Radical prostatectomy: is complete resection of the seminal vesicles really necessary? The Journal of Urology. 156: 1081-3. PMID 8709312  0.014
1997 Labrie F, Simard J, Singh SM, Candas B, Schellhammer PF, Block NL, Sharifi R, Soloway MS, Patterson AL, Vogelzang NJ, Sarosdy MF, Furr B, Caplan R, Kolvenbag GJCM. Estimated potency of casodex: A problematic design [1] (multiple letters) Urology. 50: 309-312. PMID 9255312  0.014
1985 Pollack A, Moulis H, Greenstein DB, Block NL, Irvin GL. Cell kinetic effects of incorporated 3H-thymidine on proliferating human lymphocytes: flow cytometric analysis using the DNA/nuclear protein method. Cytometry. 6: 428-36. PMID 4042784 DOI: 10.1002/cyto.990060507  0.014
1989 Block NE, Buse MG. Effects of hypercortisolemia and diabetes on skeletal muscle insulin receptor function in vitro and in vivo. The American Journal of Physiology. 256: E39-48. PMID 2643342 DOI: 10.1152/ajpendo.1989.256.1.E39  0.014
1995 Bejany DE, Block NL. Modified ileocolonic neobladder in a woman with invasive transitional cell carcinoma of the bladder. British Journal of Urology. 76: 269. PMID 7663931  0.014
1992 Komori K, Robinson KA, Block NE, Roberts RC, Buse MG. Phosphorylation of the rodent negative acute-phase protein alpha 1-inhibitor-III by the insulin receptor tyrosine kinase. Endocrinology. 131: 1288-96. PMID 1380438 DOI: 10.1210/endo.131.3.1380438  0.014
1995 Ciancio G, Ferrell S, Block NL. Flow-cytometric DNA analysis of paraffin-embedded renal cell carcinoma tissue from patients treated by parenchymal-sparing surgery. British Journal of Urology. 76: 570-4. PMID 8535674  0.013
1974 Block NL, Jaksy J, Tessler AN. Carcinoma of urinary tract. Clinical significance of urinary phosphokinase activity in diagnosis. Urology. 4: 174-81. PMID 4850881 DOI: 10.1016/0090-4295(74)90328-8  0.013
1982 Rogers B, Block N, Raskin JB. Transcutaneous ileopyelostomy fiberoptic fulguration (TIFF). New treatment of renal pelvic tumors in solitary kidney. Urology. 20: 162-5. PMID 7112821  0.013
1978 Block NL, Sigel MM, Lynne CM, Ng AB, Grosberg RA. The initiation, progress, and diagnosis of dog bladder cancer induced by 4-aminobiphenyl. Investigative Urology. 16: 50-4. PMID 689839  0.013
1976 Beraha D, Block NL, Politano VA. Simultaneous surgical management of bilateral hypernephroma: an alternative therapy. The Journal of Urology. 115: 648-50. PMID 781309  0.012
1988 Ciancio G, Pollack A, Taupier MA, Block NL, Irvin GL. Measurement of cell-cycle phase-specific cell death using Hoechst 33342 and propidium iodide: preservation by ethanol fixation. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 36: 1147-52. PMID 2457047  0.012
1993 Kwok CK, Horowitz MD, Livingstone AS, Block NL. Mature testicular teratoma with vena caval invasion presenting as pulmonary embolism. The Journal of Urology. 149: 129-31. PMID 8417194  0.011
1973 Block NL, Whitmore WF. Leukemoid reaction, thrombocytosis and hypercalcemia associated with bladder cancer. The Journal of Urology. 110: 660-3. PMID 4757547  0.011
1975 Rippe DF, Ortiz-Muniz G, Block NL, Lynne CM, Shouger RB, Sigel MM. Urinary bladder carcinogenesis in the dog: preliminary studies on cellular immunity. Transplantation Proceedings. 7: 495-501. PMID 1105912  0.011
1974 Block NL. Chemotherapy of testicular cancer. The Journal of the Florida Medical Association. 61: 817-20. PMID 4473010  0.01
1994 Ciancio G, Politano VA, Ferrell S, Block NL. Renal parenchyma-sparing surgery as conservative treatment of renal cell carcinoma. British Journal of Urology. 74: 422-30. PMID 7820417  0.01
2013 Block N. Ex libris and exchange: Immigrant interventions in the German-Jewish renaissance German Quarterly. 86: 334-353. DOI: 10.1111/gequ.10186  0.01
2005 Vincek V, Nassiri M, Block N, Welsh CF, Nadji M, Morales AR. Methodology for preservation of high molecular-weight RNA in paraffin-embedded tissue: application for laser-capture microdissection. Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. 14: 127-33. PMID 16106192 DOI: 10.1097/01.pas.0000162758.68778.41  0.01
2005 Introne RE, Block NR, Schott JR. Comparison of monochromatic and polychromatic modeling of sparse-aperture image quality Ieee Aerospace Conference Proceedings. 2005. DOI: 10.1109/AERO.2005.1559485  0.01
2004 Block NR, Introne RE, Schott JR. Image quality analysis of a spectra-radiometric sparse aperture model Proceedings of Spie - the International Society For Optical Engineering. 5418: 127-138. DOI: 10.1117/12.542419  0.01
2003 Wacke R, Park S, Mundkowski RG, Block N, Kuhn-Thiel A, Drewelow B. The penetration of moxifloxacin into the pancreas of male rats in experimental acute necrotizing pancreatitis. Chemotherapy. 49: 167-71. PMID 12886051 DOI: 10.1159/000071140  0.01
2003 Harris PK, Block NF. Potential damage to flight hardware from MIL-STD-462 CS02 setup Ieee International Symposium On Electromagnetic Compatibility. 2: 603-606.  0.01
2002 Hill MO, Holder M, Block N. Using Third Party Assumption of Environmental Liabilities to Manage Financial Risk Npra Annual Meeting Papers. 2002.  0.01
1999 Smith DB, Sacks MS, Chancellor MB, Block NL. In vivo surface geometric analysis of the urinary bladder American Society of Mechanical Engineers, Bioengineering Division (Publication) Bed. 42: 215-216.  0.01
1999 Block N. The potential for carbon sequestration projects as a mechanism for conserving forests in the Panama Canal Watershed Journal of Sustainable Forestry. 8: 53-66.  0.01
1997 Block N. Anti-reductionism slaps back Nous. 31: 107-132.  0.01
1995 Block AR, Block NL. Leiomyoma of the epididymis. The Journal of Urology. 153: 1063-5. PMID 7853564 DOI: 10.1016/S0022-5347(01)67642-0  0.01
1993 Ciancio G, Pollack A, Block NL. Flow cytometric analysis of DNA and nuclear protein in paraffin-embedded tissue. Cytometry. 14: 205-9. PMID 8440153 DOI: 10.1002/cyto.990140213  0.01
1993 Ciancio G, Civantos F, Block NL. Malignant fibrous histiocytoma of spermatic cord. Urology. 41: 55-9. PMID 8380513 DOI: 10.1016/0090-4295(93)90246-7  0.01
1993 Pollack A, Ciancio G, Terry NH, Block NL. Recognition and reduction of artifacts from autolysis in paraffin-embedded tissue using DNA/nuclear protein flow cytometry. Cytometry. 14: 565-8. PMID 8354130 DOI: 10.1002/cyto.990140517  0.01
1992 Ciancio G, Block NL. Small bowel perforation associated with intraperitoneal and extraperitoneal bladder perforation caused by stab wound to the penis. The Journal of Urology. 147: 692-5. PMID 1538461  0.01
1987 Gottlieb CF, Block NL. A technique for localized tumor hyperthermia in small animals. Medical Instrumentation. 21: 75-80. PMID 3614034  0.01
1987 Eckstein EC, Moran D, Gomez E, Pomeranz ML, Block NL, Kline J. A method for tethering dogs in a run. Laboratory Animal Science. 37: 234-5. PMID 3599898  0.01
1984 Vorstman B, Block NL, Politano VA. The management of spermatic cord liposarcomas. The Journal of Urology. 131: 66-9. PMID 6690750  0.01
1980 Weitzenfeld MB, Brown BT, Morillo G, Block NL. Scrotal kidney and ureter: an unusual hernia. The Journal of Urology. 123: 437-8. PMID 7359652  0.01
1980 Mekras GD, Block NL, Carrion HM, Ishikoff M. Urachal carcinoma: diagnosis by computerized axial tomography. The Journal of Urology. 123: 275-7. PMID 6243712  0.01
1978 Kline J, Eckstein EC, Block NL, Lyon F, Kelly R, Morgan D, Ehrlich S. Development of a total prosthetic urinary bladder. Transactions - American Society For Artificial Internal Organs. 24: 254-6. PMID 716009  0.01
1978 Rodrigo JJ, Block N, Thompson EC. Joint transplantation. The Veterinary Clinics of North America. 8: 523-38. PMID 364812  0.01
1977 Block NL, Camuzzi F, Denefrio J, Troner M, Claflin A, Stover B, Politano VA. Chemotherapy of the transplantable adenocarcinoma (R-3327) of the Copenhagen rat. Oncology. 34: 110-3. PMID 917440 DOI: 10.1159/000225202  0.01
1977 Block NL, Stover E, Politano VA. A prosthetic ureter in the dog. Transactions - American Society For Artificial Internal Organs. 23: 367-70. PMID 910358  0.01
1974 Block NJ, Dworkin G. IQ, heritability and inequality, part 2. Philosophy & Public Affairs. 4: 40-99. PMID 11661096  0.01
1974 Beraha D, Block NL, Politano VA. Myelolipoma of the kidney. The Journal of Urology. 112: 19-21. PMID 4835071  0.01
1974 Gordon JA, Machiz S, Block NL, Politano VA. Salmonella typhosa infection of kidney. Urology. 3: 470-2. PMID 4822696 DOI: 10.1016/S0090-4295(74)80166-4  0.01
1974 Block NL, Morales P, Fazzini EP. Acutely traumatized canine ureter. Effects of low molecular weight dextran and surfactant pluronic F-68. Urology. 3: 190-4. PMID 4812663 DOI: 10.1016/S0090-4295(74)80012-9  0.01
1973 Golimbu M, Block N, Morales PA. Ureterovesical flap operation for middle and upper ureteral repair. Investigative Urology. 10: 313-7. PMID 4683383  0.01
1973 Block NL, Grabstald HG, Melamed MR. Congenital mesoblastic nephroma (leiomyomatous hamartoma): first adult case. The Journal of Urology. 110: 380-3. PMID 4355052  0.01
1971 Block NL, Tessler AN. Transsexualism and surgical procedures. Surgery, Gynecology & Obstetrics. 132: 517-25. PMID 4925941  0.01
1940 Block NB, Ferguson W. An Outbreak of Shiga Dysentery in Michigan, 1938. American Journal of Public Health and the Nation's Health. 30: 43-52. PMID 18015161  0.01
Hide low-probability matches.